Canaccord Lowers Artivion Price Target to $48, Keeps Buy Rating Citing Market Multiple Compression
Canaccord Genuity cut its price target on Artivion Inc. (AORT) to $48 from $51 but maintained a Buy rating, citing compressed valuation multiples across comparable groups during the recent market downturn. The new target implies roughly 26% upside from the current share price of $38. Artivion reported stronger-than-expected adjusted Q4 revenue and …